Halberd Corporation (HALB) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Jackson Center, PA, 美国. 现任CEO为 William A. Hartman.
HALB 拥有 IPO日期为 2012-09-25, 在 Other OTC, 市值为 $484.92K.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
